Fundraising Fox

Dstp

Public Β· 1 known investors

Manufacturer of advanced materials for semiconductors, displays, batteries, and pharmaceutical intermediates. Supplies core materials to technology and life-science manufacturers, targeting the global semiconductor and energy markets.

Also known as DS Techopia Β· Duksan Techopia Β· Duksan Tecopia Co., Ltd. Β· λ•μ‚°ν…Œμ½”ν”Όμ•„

Investors Β· 1

Company profile

researched Aug 2026

Duksan Techopia (λ•μ‚°ν…Œμ½”ν”Όμ•„, DS Techopia) is a South Korean specialty fine-chemical synthesis company producing base and advanced materials for the electronics, energy and life-science industries. Its declared business lines are semiconductor materials, OLED/display materials, battery materials, pharmaceutical intermediates and functional chemical materials. In semiconductors it develops and manufactures ALD/CVD precursors used as thin-film deposition compounds, and it also supplies ultra-high-purity sources for optical fiber, positioning it in both the semiconductor and optical-communication supply chains. On the display side it develops high-purity OLED materials including organic fluorescent and phosphorescent substances.

The company operates an in-house technology research institute covering research fields and process technology development, and publishes an ESG program spanning environmental management, safety and health, quality management, ethical management (with a code of ethics, whistle-blowing channel at ethics@dstp.co.kr) and information protection. It is part of the Duksan group of affiliated companies, with related entities including Duksan Industrial (덕산산업), Duksan Electera (λ•μ‚°μΌλ ‰ν…ŒλΌ) and Duksan Futurecell (λ•μ‚°ν“¨μ²˜μ…€).

Business model

Manufacture and supply of high-purity chemical materials and intermediates to electronics, battery and pharmaceutical manufacturers, organized into semiconductor, OLED/display, battery, pharmaceutical-intermediate and functional-chemical material divisions, supported by an internal R&D institute [0][2].

Latest developments

In March 2024 the company announced entry into biopharmaceutical CDMO, based on mass production of pharmaceutical intermediates. In April 2024 press reported it had secured a roughly 10,000-pyeong site in Gongju for annual production of 1,000 tons of battery electrolyte additive, and that its valuation was the highest since its 2019 listing. December 2024 coverage described vertical integration of the secondary-battery business with subsidiary Duksan Electera, with additive supply to that affiliate planned from 2025. In March 2025 Duksan Electera announced start-up of its Tennessee electrolyte plant [0].

β–ΈFull profile β€” market position, technology, go-to-market, geography, history

Market position

Describes itself as a specialist base- and advanced-materials company in electronic materials and display materials; a securities research note characterized it as an OLED-to-semiconductor materials specialist increasingly viewed as a secondary-battery materials company [0][2].

Technology

Fine chemical synthesis of electronic materials: high-purity OLED materials including organic fluorescent and phosphorescent compounds; ALD/CVD precursors for thin-film deposition in semiconductor manufacturing; ultra-high-purity sources for optical fiber; electrolyte additives for secondary batteries; and pharmaceutical intermediates produced through precision synthesis processes [0][2].

Go-to-market

Semiconductor, display, secondary-battery and optical-communication manufacturers, plus pharmaceutical companies buying intermediates; the group's electrolyte affiliate targets Chinese and Japanese customers from its US plant [0][2].

Geography

Headquartered in Korea with three sites in Chungcheongnam-do: the DP materials division and head office at 39 Pungsesandan 2-ro, Dongnam-gu, Cheonan-si; the semiconductor division at 30, 5sandan 3-ro, Seongnam-myeon, Dongnam-gu, Cheonan-si (31245); and the fine chemicals division in Gongju. The company site is published in Korean, English, Japanese and Chinese. Affiliate Duksan Electera operates an electrolyte plant in Tennessee, United States [0][1][2].

History

Press coverage states the company has been listed since 2019. Its site publishes a corporate history section, CEO message, affiliate list and network. It has been a SEMI member company since June 2011 [0][2].

Compiled by commissioned research from 8 cited public sources β€” announcements, filings, and press listed under research sources below.

Key figures

latest reported
Planned electrolyte additive production capacityApr 20241,000 tons per year
Share priceJan 202510,870 KRW

Company-reported or press-reported figures, each dated to when it was claimed β€” not independently audited.

Timeline Β· 6

launches, deals, and filings
Mar 2025
Affiliate Duksan Electera starts operation of Tennessee electrolyte plant

Duksan Electera announced it had begun operating an electrolyte plant built in Tennessee, United States, completed following works from October of the prior year, to supply Chinese and Japanese customers.

source β†—

Dec 2024
Vertical integration of secondary-battery business with Duksan Electera

Coverage described a growth strategy of vertically integrating the secondary-battery business with subsidiary Duksan Electera, supplying electrolyte additive to the electrolyte-making subsidiary from 2025 to offset the electric-vehicle market slowdown.

source β†—

Apr 2024
Gongju site secured for 1,000-ton annual electrolyte additive production

Press reported the company had secured a site of about 10,000 pyeong in Gongju for annual mass production of 1,000 tons of secondary-battery electrolyte additive, part of its new business build-out since its 2019 listing.

source β†—

Apr 2024
Affiliate Duksan Futurecell obtains European patent for semi-solid secondary battery technology

Duksan Futurecell announced it had obtained a European patent for 'composite solid electrolyte for secondary battery and method of manufacturing the same', supporting entry into all-solid-state and semi-solid battery business.

source β†—

Mar 2024
Entry into bio CDMO business based on pharmaceutical intermediate production

The company announced it was entering the biopharmaceutical contract development and manufacturing (CDMO) business, selecting bio as a growth driver alongside its semiconductor and display materials operations, with mass production of pharmaceutical intermediates.

source β†—

Jun 2011
Joined SEMI as a member company

Listed in the SEMI member directory as a member since 28 June 2011, member ID 222075, primary industry semiconductor, primary product category materials (chemicals and gases).

source β†—

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

β–ΈResearch sources Β· 8

primary sources listed
  • Dstpdstp.co.kr Β· web

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Dstp do?
Korean fine-chemical maker of semiconductor, OLED, battery and pharmaceutical-intermediate materials, listed and based in Chungcheongnam-do.
Who are Dstp's investors?
Dstp's investors include Kiwoom Investment.